Literature DB >> 10719598

[Outcome factors in severe skull-brain trauma. A retrospective analysis of 228 (161) patients].

A Thomas1, H G Berlinghof, K H Bock, L Lampl.   

Abstract

OBJECTIVE: To study outcome from severe head injury (SHI: GCS < or = 8) and to investigate impact of prehospital factors and clinical intensive care parameters on outcome. To compare with former study results (1980-88) of our clinical setting.
METHODS: Retrospectively, the history of 228 patients with SHI treated between 1988 and 1995 was looked into. The outcome was measured with the Glasgow Outcome Scale (GOS) post intensive care (median 9, min-max 2-77 days) and 6 months after trauma by a questionnaire. The GOS was related to age, Glasgow Coma Scale (GCS on the scene), prehospital hypotension and hypoxia (HH), intracranial pressure (ICP), cerebral perfusion pressure (CPP), intensive therapy including Tromethamine and/or Thiopentone. The rate of infections was determined.
RESULTS: Increasing age influences outcome negatively. Prehospital GCS and HH were significantly correlated with outcome. GOS of 30 patients with HH: GOS 1: 53%, GOS 2 + 3: 27%, GOS 4 + 5: 20%. GOS of 40 patients without HH: GOS 1: 25%, GOS 2 + 3: 10%, GOS 4 + 5: 65%. During intensive care the level of CPP (not ICP) as well as tromethamine and/or thiopentone treatment for control of elevated ICP were significantly correlated with outcome. Mortality rate in 32 patients with CPP < 50 mmHq was 69%, in 29 patients with CPP > 50 mmHg only 20%. Patients treated additionally with Tromethamine and Thiopentone because of uncontrollable intracranial hypertension showed a significantly worse outcome: GOS 1: 66%, GOS 2 + 3: 6%, GOS 4 + 5: 28%, compared to those who needed neither Tromethamine nor Thiopentone: GOS 1: 27%, GOS 2 + 3: 18%, GOS 4 + 5: 55%. Thiopentone treatment was not associated with an increased rate of pulmonary and other infections. In comparison to our former outcome study, covering the years 1980-88, we have not seen any improvements in outcome, despite modifications in intensive care protocols.
CONCLUSIONS: Prehospital hypotension and hypoxia have a significant negative impact on outcome by causing secondary brain damage. Despite various modifications in intensive care therapy an unchanged portion of secondary brain damage will not prove treatable. Therefore, prevention or early aggressive treatment of hypotension and hypoxia is the most promising way of improving outcome after severe head injury at the moment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10719598     DOI: 10.1055/s-2000-13006

Source DB:  PubMed          Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther        ISSN: 0939-2661            Impact factor:   0.698


  5 in total

Review 1.  Maintaining cerebral perfusion pressure is a worthy clinical goal.

Authors:  Geoffrey S F Ling; Chris J Neal
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  [Vasopressin for therapy of persistent traumatic hemorrhagic shock: The VITRIS.at study].

Authors:  H G Lienhart; V Wenzel; J Braun; V Dörges; M Dünser; A Gries; W R Hasibeder; M Helm; R Lefering; T Schlechtriemen; H Trimmel; H Ulmer; W Ummenhofer; W G Voelckel; C Waydhas; K Lindner
Journal:  Anaesthesist       Date:  2007-02       Impact factor: 1.041

3.  Circadian variability of the initial Glasgow Coma Scale score in traumatic brain injury patients.

Authors:  John K Yue; Caitlin K Robinson; Ethan A Winkler; Pavan S Upadhyayula; John F Burke; Romain Pirracchio; Catherine G Suen; Hansen Deng; Laura B Ngwenya; Sanjay S Dhall; Geoffrey T Manley; Phiroz E Tarapore
Journal:  Neurobiol Sleep Circadian Rhythms       Date:  2016-10-11

4.  Preclinical care of children with traumatic brain injury (TBI).

Authors:  Peter Sefrin; Michael Brandt; Markus Kredel
Journal:  Ger Med Sci       Date:  2004-03-10

5.  Paradoxical Herniation After Unilateral Decompressive Craniectomy Predicts Better Patient Survival: A Retrospective Analysis of 429 Cases.

Authors:  Weiqiang Chen; Jingfang Guo; Jin Wu; Guoyi Peng; Mindong Huang; Chuwei Cai; Yingming Yang; Shousen Wang
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.